{"disease":{"id":"transthyretin-amyloidosis-cardiomyopathy-heart-failure-with-preserved-ejection-fraction","name":"transthyretin amyloidosis cardiomyopathy heart failure with preserved ejection fraction"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06338839","title":"Transthyretin Amyloidosis Cardiomyopathy in Patients With HFpEF in Russia","phase":"","overall_status":"TERMINATED","enrollment_count":1770,"lead_sponsor_name":"AstraZeneca","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}